Coronavirus Update

The U.S. biopharmaceutical industry is working closely with U.S. government agencies, the World Health Organization and governments around the world to identify their most pressing needs in the areas of vaccination, diagnostics, and antivirals and other treatments, and to facilitate collaborations with industry.

To learn more about what the biopharmaceutical industry is doing to combat the virus and for a host of information and helpful resources (FAQ’s, CDC Information Hub, Safety Tips, etc.)
Slide One
Slide Two
Slide Three

On Nov. 10, 2020, BioWV hosted a webinar on the status of vaccines and therapeutics in development to combat COVID-19 and the plan for rolling out the vaccine(s) in West Virginia, once available.

The event featured Phyllis Arthur, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization (BIO), and Dr. Clay Marsh, Vice President & Executive Dean for Health Sciences at West Virginia University and COVID-19 Czar for the State of West Virginia. 

PO BOX 20065 | Charleston, WV 25362 | (304) 546-5500